Jump to main content
Jump to site search

Issue 80, 2015
Previous Article Next Article

An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C–C bond formation

Author affiliations

Abstract

Fulvestrant (Faslodex®) was synthesized in four steps (35% overall yield) from 6-dehydronandrolone acetate. Catalyst controlled, room temperature, diastereoselective 1,6-addition of the zirconocene derived from commercially available 9-bromonon-1-ene was used in the key C–C bond forming step.

Graphical abstract: An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C–C bond formation

Back to tab navigation

Supplementary files

Publication details

The article was received on 13 Jul 2015, accepted on 17 Aug 2015 and first published on 17 Aug 2015


Article type: Communication
DOI: 10.1039/C5CC05805H
Author version
available:
Download author version (PDF)
Chem. Commun., 2015,51, 14866-14868

  •   Request permissions

    An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C–C bond formation

    D. Caprioglio and S. P. Fletcher, Chem. Commun., 2015, 51, 14866
    DOI: 10.1039/C5CC05805H

Search articles by author

Spotlight

Advertisements